Buy cheap drugs online. FDA approved generic medications. Safe medicine

Wiki drugs, medical news, drug store online.


ED Treatment
1. Viagra - $ 1.15 per pill
2. Cialis - $ 1.99 per pill
3. Levitra - $ 2.93 per pill

Best Packs
Our Customers Say
I got to say.... Your service is absolutely superb! I just received my order in the mail. You have just gotten yourself a steady very impressed satisfied customer. Thank you for your excellent service.
Sam Brody, Jersey City, NY






Subscribe in a reader
U.S. authorities have recently permitted Dynavax Technologies Corp to resume trials of Hepatitis B vaccine. As a result, 73% of the Company's shares went up in the pre-market trading.

Last November the company's shares dropped to 15 cent each that equal to more than $10.00 per a share at the end of 2006. In the pre-marketing trading the company received $3.03 up in Wednesday close deal of $1.75. The investors in Heplisav vaccine shall be pleasantly surprised with the news that after 18 months on clinical hold the product for safety by the USA Food and Drug Administration there has been given the permit for Dynavax to start immunization of the patients suffering from chronic kidney illness and obtaining negative results of treatment from the current medicine.

Actually there is no cure for liver cirrhosis led with hepatitis B. Nowadays there is Engerix-B vaccine produced by GlaxoSmithKline Plc and available at the market. But Heplisav could be more effective with fewer dosage and administration that Engerix-B as Dynavax specialists considered.

Last march it happened that Heplisav was frozen by the FDA. The reason was the case of Wegener's granulomatosis that was developed in a patient that affected blood vessels and caused extensive tissue damage. The genetically engineered viral antigen with adjuvant is in content of Heplisav for the vaccine creation. Adjuvant designed to improve the efficiency of antigen targets Toll-like receptor 9, a protein that instructs the immune system for self-activation.

The final phase of the vaccine study has been done by Dynavax established in Berkeley, California with announcement to enroll patients in the testing for comparison the vaccine produced for commercial purposes with the vaccine produced for clinic trials. The subject for this study is to ensure the both vaccines are similarly effective.

For development of unique influenza vaccine used against seasonal and pandemic flu different forms of its adjuvant is used by Dynavax in the pre-clinical development these days.

Tags: Hepatitis B, FDA, Dynavax, Heplisav, blood vessels, influenza vaccine
Print page

Enter your email address:

Delivered by FeedBurner


Home Page|F.A.Q.|Moneyback Policy|Privacy Policy|Shipping Policy|Customer Support
Our website is not associated with drug manufacturers. Our online drug store is also not affiliated
with the pharmaceutical manufacturers of the products, we sell only generic drugs.
2009 © Copyright. All Rights Reserved.